freehealth.ai01 / 28freehealth.ai01 / 28
Investor presentation · October 2026
Board and advisors
Board
Sulaiman MustaphaCo-Founder, Board of Directors
Matt ConstantinoManaging Partner, Delos Capital
Sumit NagpalCEO, Cherish · HIMSS Board MemberAdvisory board
The film
Chapter one
Scattered across a patient’s doctors.
Wearables capture daily changes outside the record.
Symptoms, mood and medication routines get lost.
People need help preparing for the next visit.
Introducing FreeHealth.ai
Your records, labs and wearables — together in one health history, explained in plain English.
The FreeHealth experience
Morning scan
Your digital twin
Your vitals
Illustrative product UI. Generated likenesses and demo metrics; not a medical reading.
Care, connected
1 Ask Maya
2 Book a visit
3 Get the summary
4 Pick it up
Patient-authorized record retrieval
Authorize retrieval from current doctors and providers.
Records, lab reports and care documentation.
Clinical history plus wearable signals, check-ins and context.
Patient authorization and applicable HIPAA access requirements govern retrieval.
Chapter two
Strategic investment
An investment in Mother Nature AI. Each company keeps its own team and brand.
Mother Nature’s AI portfolio and VitalIQ devices, inside FreeHealth.
New wearables, developed together and connected from day one.
Connected devices
Screenless. Passive. Always on.
Joint venture · New wearables
Daily signals. v2 is next.
Consented visit notes for clinicians.
Ongoing cardiac sensing.
Check-ins for home and elderly care.
Deployment status is company-reported. Concept artwork; specifications and clinical suitability require validation.
The care opportunity
Everyday reassurance, shared with permission.
Resident trends and AI-assisted follow-up.
Licensed AI portfolio
0
medicinal plants and herbs, behind a simpler experience.
Education, labs and integrative wellness.
Support for mood, stress and daily life.
Food journals and personal plans.
On the longer-term roadmap.
Company-reported library. Educational tools; review suitability with a qualified clinician.
Chapter three
Foundation and commercial pipeline
0
Company-reported since 2022. Conversations, not unique or active users.
0
$20 per member per month over a proposed 24-month term — $8.4M in illustrative annual platform fees.
Definitive agreement and launch conditions remain outstanding. No committed revenue or guaranteed enrollment.
Market context
$0T
U.S. healthcare spending, 2024
0M
U.S. adults age 65+, 2024
CMS National Health Expenditure, 2024; U.S. Census ACS, 2024. Context only — not FreeHealth’s TAM or forecast.
Business model
Pre-revenue. All economics are proposed; nursing-home pricing requires pilot validation.
Commercialization strategy
Clinical evidence and a controlled release.
Bracelets with facility dashboards; pilots prove the economics.
Free access builds trust; premium and bracelets follow.
First milestone · Clinical evidence
Oversight, pilot settings, consent, endpoints.
Prototype testing and manufacturing readiness.
Methods, results and limitations.
Controlled release with quality checks.
Proposed infrastructure
An initial data center for the AI platform — built in stages, sized by measured workload.
1 · Design and site → 2 · First GPU capacity → 3 · Production readiness → 4 · Expansion gate
Trust and validation
Permissioned sharing, export and deletion.
Clinicians own diagnosis and treatment.
Validate before expanding use cases.
Access controls, audit trails, retention.
Planned infrastructure, not existing capacity. No FDA clearance, reimbursement eligibility or HIPAA certification is asserted.
Execution milestones
Run the trials. Finish v2. Publish and ship.
Bracelet into FreeHealth. Deploy the AI. First GPUs.
Pilots into offers. Paid packaging. Scale with demand.
Leadership
Richie HoseinCEO & Founder
Shawna SmithChief Operating Officer
Dr. Shmuel AgusChief Medical Officer
Jennifer GalarzaChief Marketing Officer
Jason SchwartzChief Creative DirectorStrategic partner team
Proposed use of funds
$0M
Focused on evidence, VitalIQ v2 and the platform.
Oversight, execution, publication
Hardware, testing, production
iOS, integration, AI deployment
Site, first capacity, infrastructure
Security, legal, team, partnerships
Illustrative allocation for management review. Final amounts depend on protocols, hardware costs and the infrastructure plan.
The investment
$0M
Capital raise
SAFE
Simple Agreement for Future Equity
$0M
Post-money valuation cap
Definitive SAFE documents govern conversion and investor rights. No liquidity or return is guaranteed.
Appendix · Provider experience
Daily habits, mood and follow-through.
Care-plan history focuses the next conversation.
Care teams make medication and treatment decisions.
Illustrative UI. Clinical use requires separate validation.